ArticleFrontiers in pediatrics2026
Late-onset group B streptococcal septic arthritis in an afebrile neonate: a case report.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The majority of neonatal group B streptococcal (GBS) infections present as sepsis or meningitis, while osteoarticular involvement is rare during the neonatal period. We report a case of culture-confirmed late-onset GBS septic arthritis in a 26-day-old male neonate presenting with progressive swelling, erythema, and irritability of the left knee without fever. Surgical irrigation and debridement revealed purulent arthritis. Because maternal prenatal records, maternal GBS screening status, and maternal infectious disease history were unavailable, a catheterized urine polymerase chain reaction (PCR) panel for sexually transmitted infections and genital tract-associated pathogens was obtained during the evaluation of a possible vertically or perinatally transmitted infection. The panel was positive for GBS on hospital day 0, approximately 72 h before joint tissue culture confirmation. Joint tissue culture subsequently yielded GBS, while blood and cerebrospinal fluid cultures remained sterile. The patient was treated successfully with intravenous ampicillin after initial empiric therapy with ampicillin and gentamicin. Clinical recovery and ultrasonographic resolution of joint effusion were achieved, and no clinical sequelae were detected at the 3-month post-discharge follow-up. This case emphasizes that afebrile neonates with progressive monoarticular swelling should be evaluated for septic arthritis and that definitive diagnosis relies on microbiological confirmation from a sterile-site specimen. The urine PCR finding, in this case, is reported as a hypothesis-generating observation in a neonate with unavailable maternal screening data; however, its biological significance remains uncertain and should not be interpreted as validation of urine PCR for invasive neonatal GBS disease or septic arthritis
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.